Background: Studies of patients meeting clinical and pathologic criteria fo
r Alzheimer disease (AD) have not consistently found associations between t
he presence of Lewy bodies (LBs) at postmortem examination and a higher fre
quency during life of the clinical features of dementia with LBs.
Objective: To evaluate the clinical correlates of LBs in patients with XD.
Design and Methods: Fifty-one patients were diagnosed as having probable AD
during life and met pathologic criteria for AD. Semiquantitative ratings f
or LBs were obtained in 4 brain regions: substantia nigra, cingulate, insul
ar cortex, and hippocampus. The patients had been followed up semiannually
for up to 9.9 years before death, and clinical features associated with dem
entia with LBs, including extrapyramidal signs and visual hallucinations, w
ere assessed at each study visit. logistic regression analyses determined w
hether patients who had LBs were more likely than those without LBs to expr
ess specific clinical signs during follow-up. Cox analyses determined wheth
er patients with LBs developed clinical signs or died earlier. Generalized
estimating equations were used to compare rates of cognitive or functional
change.
Results: Nineteen of the 51 patients had at least 1 LB in one of the studie
d regions. In no case was a significant relation noted between LBs and the
presence of a measured clinical sign. No LB measure was associated with an
increased risk of developing any of the evaluated clinical signs earlier in
the disease. There was no association between the presence of LBs and more
rapid mortality or more rapid disease progression.
Conclusions: In patients diagnosed as having AD during life, we did not obs
erve a relation of LBs noted during postmortem examination with the presenc
e of any clinical feature that we assessed or with the rapidity of disease
progression. The relation between LBs and specific clinical manifestations
may be tenuous in these patients.